From: One-year observation of leflunomide effectiveness and saftey in juvenile idiopathic arthritis : a clinical practice review (preliminary data)
*median
baseline
3 M
12 M
SJC
2.54
0.64
0
TJC
2.61
1.07
0.07
LRMC
2.14
1.57
0.92